MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

20 20 Biolabs, Inc. (AIDX)

20 20 Biolabs, Inc. (AIDX)

||
||

Cash Flow Overview

Change in Cash
$327,041
Unit: Dollar
Positive Cash Flow Breakdown
    • Proceeds from issuance of series...
    • Stock based compensation
    • Loss on issuance of convertible ...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accounts receivable
    • Offering costs
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
Net loss
-1,506,344
-2,174,836
-3,738,821
Depreciation and amortization
12,304
12,306
63,257
Stock based compensation
371,300
128,440
516,180
Amortization of license fees
7,500
5,625
22,500
Issuance of common stock for services
81,500
100,000
-
Loss on issuance of convertible note
322,359
-
-
Amortization of right-of-use assets, net of liabilities
3,118
3,120
7,781
Amortization of debt discount
275,213
240,370
115,184
Change in fair value of derivative liability
0
-148,766
-7,737
Loss on issuance of convertible note
-
-322,359
-280,764
Accounts receivable
90,005
1,527
64,682
Inventory
6,513
-11,694
69,052
Prepaid expenses and other assets
-48,213
46,199
-77,705
Accounts payable
46,324
111,941
496,242
Accrued liabilities
172,565
-202,448
419,263
Interest payable
-
26,634
41,023
Deferred revenue
12,235
31,035
-63,765
Net cash used in operating activities
-605,460
-1,288,960
-1,919,720
Purchases of intangible assets, including patents
0
5,354
-
License agreement
7,500
-
-
Net cash used in investing activities
-7,500
-5,354
-
Proceeds from issuance of convertible notes payable
0
250,000
988,472
Proceeds from issuance of series d preferred stock
-
-
192,338
Proceeds from issuance of pre-delivery shares
-
-
4,750
Proceeds from issuance of series e convertible preferred stock
1,000,000
5,000,000
-
Offering costs
59,999
762,574
23,862
Net cash provided by financing activities
940,001
4,487,426
1,161,698
Increase (decrease) in cash and cash equivalents
327,041
3,193,112
-758,022
Cash and cash equivalents, beginning of period
4,219,099
1,025,987
1,784,009
Cash and cash equivalents, end of period
4,546,140
4,219,099
1,025,987
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

AIDX Cash Flow Sankey DiagramSankey diagram visualizing AIDX cash flow for the periodProceeds from issuance ofseries e convertible...$1,000,000 Net cash provided byfinancing activities$940,001 Canceled cashflow$59,999 Increase (decrease) incash and cash...$327,041 Canceled cashflow$612,960 Offering costs$59,999 Stock basedcompensation$371,300 Loss on issuance ofconvertible note$322,359 Amortization of debt discount$275,213 Accrued liabilities$172,565 Issuance of common stockfor services$81,500 Prepaid expenses andother assets-$48,213 Accounts payable$46,324 Depreciation andamortization$12,304 Deferred revenue$12,235 Amortization of license fees$7,500 Net cash used inoperating activities-$605,460 Net cash used ininvesting activities-$7,500 Canceled cashflow$1,349,513 Net loss-$1,506,344 License agreement$7,500 something is missing-$348,993 Accounts receivable$90,005 Inventory$6,513 Amortization of right-of-useassets, net of...$3,118